Download PDF
Nuklearmedizin 2010; 49(04): N20-N21
DOI: 10.1055/s-0038-1626513
Case report
Schattauer GmbH

Splenic sclerosing haemangioma causes false-positive finding at FDG-PET

A. Al-Ibraheem
1   Dept. of Nuclear Medicine, Technische Universität München, Germany
,
A. K. Buck
1   Dept. of Nuclear Medicine, Technische Universität München, Germany
,
T. Dechow
2   Medical Dept., Hematology / Oncology, Technische Universität München, Germany
,
I. Ringshausen
2   Medical Dept., Hematology / Oncology, Technische Universität München, Germany
,
R. Langer
3   Dept. of Pathology, Technische Universität München, Germany
,
H. P. Engels
4   Dept. of Radiology, Technische Universität München, Germany
,
H. A. Wieder
4   Dept. of Radiology, Technische Universität München, Germany
,
J. Sciuk
5   Dept. of Nuclear Medicine, Klinikum Augsburg, Germany
,
M. Schwaiger
1   Dept. of Nuclear Medicine, Technische Universität München, Germany
,
K. Herrmann
1   Dept. of Nuclear Medicine, Technische Universität München, Germany
› Author Affiliations
Further Information

Publication History

Received: 14 January 2010

accepted in revised form: 12 May 2010

Publication Date:
25 January 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Abbott RM, Levy AD, Aguilera NS. et al. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics 2004; 24: 1137-1163.
    CrossrefPubMedGoogle Scholar
  • 2 Cheuk W, Chan J. Mesenchymal tumors and tumorlike lesions of the spleen. In: Fletcher C. (ed) Diagnostic Histopathology of Tumors. 2007; 1304-1309.
    PubMedGoogle Scholar
  • 3 Rabushka LS, Kawashima A, Fishman EK. Imaging of the spleen: CT with supplemental MR examination. Radiographics 1994; 14: 307-332.
    CrossrefPubMedGoogle Scholar
  • 4 Ramani M, Reinhold C, Semelka RC. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology 1997; 202: 166-172.
    CrossrefPubMedGoogle Scholar
  • 5 Shintaro N, Minori S, Yuji I. et al. A case of splenic sclerosing hemangioma. J Japan Surg Assoc 2004; 65: 2468-2472.
    Google Scholar
  • 6 Rini JN, Leonidas JC, Tomas MB. et al. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 2003; 44: 1072-1074.
    PubMedGoogle Scholar
  • 7 Kobe C, Dietlein M, Mauz-Körholz C. FDG-PET in Hodgkin lymphoma. Nuklearmedizin 2008; 47: 235-238.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Doyle DJ, Khalili K, Guindi M, Atri M. Imaging features of sclerosed hemangioma. AJR Am J Roentgenol 2007; 189: 67-72.
    CrossrefPubMedGoogle Scholar
  • 9 Edoute Y, Ben-Haim SA, Ben-Arie Y. et al. Difficult preoperative diagnosis of a patient with sclerosing splenic hemangioma. Am J Gastroenterol 1989; 84: 817-819.
    Google Scholar
  • 10 Metser U, Miller E, Kessler A. Solid splenic masses: evaluation with 18F-FDG PET/CT. J Nucl Med 2005; 46: 52-59.
    PubMedGoogle Scholar
  • 11 La Fougère C, Pfluger T, Schneider V. Restaging of patients with lymphoma – Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT. Nuklearmedizin 2008; 47: 37-42.
    Article in Thieme ConnectPubMedGoogle Scholar